Evidence map›Paper›PMID 41708935›Full record

ArticleAnnals of surgical oncology2026

Interplay of Tumor Morphology and Biology with Postoperative Complications: Prognostic Implications After Resection of Colorectal Liver Metastasis.

Abdullah Altaf, Miho Akabane, Kathleen Tong, Mujtaba Khalil, Zayed Rashid, Shahzaib Zindani, Azza Sarfraz, Areesh Mevawalla, Andrea Ruzzenente, Luca Aldrighetti and 7 more

Abstract read
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Abdullah AltafDepartment of Surgery, Division of Surgical Oncology, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Miho AkabaneDepartment of Surgery, Division of Surgical Oncology, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Kathleen TongDepartment of Surgery, Division of Surgical Oncology, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Mujtaba KhalilDepartment of Surgery, Division of Surgical Oncology, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Zayed RashidDepartment of Surgery, Division of Surgical Oncology, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Shahzaib ZindaniDepartment of Surgery, Division of Surgical Oncology, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Azza SarfrazDepartment of Surgery, Division of Surgical Oncology, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Areesh MevawallaDepartment of Surgery, Division of Surgical Oncology, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Andrea RuzzenenteDepartment of Surgery, University of Verona, Verona, Italy.
Luca AldrighettiDepartment of Surgery, San Raffaele Hospital, Milan, Italy.
Irinel PopescuDepartment of Surgery, Fundeni Clinical Institute, Bucharest, Romania.
Minoru KitagoDepartment of Surgery, Keio University, Tokyo, Japan.
George PoultsidesDepartment of Surgery, Stanford University School of Medicine, Stanford, CA, USA.
Kazunari SasakiDepartment of Surgery, Stanford University School of Medicine, Stanford, CA, USA.
Federico AucejoDepartment of Surgery, Cleveland Clinic Foundation Main Campus, Cleveland, OH, USA.
Itaru EndoDepartment of Surgery, Yokohama City University School of Medicine, Yokohama, Japan.
Timothy M PawlikDepartment of Surgery, Division of Surgical Oncology, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA. Tim.Pawlik@osumc.edu.ORCID http://orcid.org/0000-0002-7994-9870

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe sought to evaluate the differential prognostic impact of postoperative complications on recurrence-free survival (RFS) and overall survival (OS) relative to clinicopathologic and clinical biologic indicators associated with colorectal liver metastases (CRLM).

methodsPatients who underwent curative-intent resection for CRLM between 2000 and 2023 were identified from an international, multi-institutional database. The Genetic And Morphological Evaluation (GAME) score was utilized to risk stratify patients based on KRAS status, carcinoembryonic antigen levels, primary tumor lymph node metastasis, tumor burden score, and extrahepatic disease. The comprehensive complication index (CCI) was used to categorize postoperative complications.

resultsAmong 887 patients included in the analytic cohort, the overall incidence of postoperative morbidity was 22.3% (n = 197), with 18.8% (n = 167) of patients having a high CCI (≥ 26.2). Overall, on multivariable Cox regression analysis, high CCI was independently associated with worse RFS (hazard ration [HR] 1.45 [95% confidence interval {CI} 1.18 - 1.78]; p = 0.001) but not with OS (HR 1.14 [95% CI 0.98 - 1.27]; p = 0.075). Among patients with a low GAME score, high CCI was associated with both worse RFS (HR 2.17 [95% CI 1.55 - 3.03]; p = 0.001) and worse OS (HR1.78 [95% CI 1.22 - 2.58]; p = 0.001). In contrast, among patients with medium- and high-risk GAME scores, high CCI was associated with neither RFS (HR 0.97 [95% CI 0.70 - 1.34]; p = 0.540) nor OS (HR 0.99 [95% CI 0.67 - 1.46]; p = 0.290).

conclusionPostoperative complications had a variable prognostic impact on patients undergoing resection for CRLM depending on the severity of the complication and the overall biologic risk of the underlying disease. Patients with more favorable underlying tumor biology were more likely to have adverse oncologic long-term outcomes after experiencing severe postoperative complications.

Indexed as

Colorectal NeoplasmsHepatectomyLiver NeoplasmsPostoperative ComplicationsAgedFemaleFollow-Up StudiesHumansLymphatic MetastasisMaleMiddle AgedPrognosisSurvival RateColorectal liver metastasisLiver resectionOverall survivalPostoperative complicationsRecurrence-free survivalTumor biology

Identifiers

PMID41708935
PMCPMC13083369

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.